| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $125K | -92.3% |
| Cost of Revenue | $73K | -7.2% |
| R&D Expense | $2.1M | +8162.7% |
| SG&A Expense | $25.9M | +249.4% |
| Operating Income | -$180.9M | -1553.8% |
| Income Tax | $0 | — |
| Net Income | -$233.1M | -1740.6% |
| EPS (Basic) | -$13.37 | -476.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.8M | +1368.8% |
| Accounts Receivable | $32K | -95.7% |
| Current Assets | $42.8M | +1821.5% |
| Total Assets | $52.9M | +963.6% |
| Current Liabilities | $4.3M | +18.7% |
| Total Liabilities | $5.2M | -0.1% |
| Stockholders' Equity | $47.7M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $0 | -100.0% |